Late presentation during the COVID-19 pandemic of severe procidentia: a high-grade poorly differentiated sarcoma of unknown origin

Christina Pappa; Sarah Louise Smyth; Hooman Soleymani Majd

doi:10.1136/bcr-2021-246710

Late presentation during the COVID-19 pandemic of severe procidentia: a high-grade poorly differentiated sarcoma of unknown origin

BMJ Case Rep. 2022 Feb 9;15(2):e246710. doi: 10.1136/bcr-2021-246710.

Authors

Christina Pappa¹, Sarah Louise Smyth¹, Hooman Soleymani Majd^{2

3}

Affiliations

¹ Department of Gynaecology Oncology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
² Department of Gynaecology Oncology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK hooman.soleymani@ouh.nhs.uk.
³ Nuffield Department of Women's Reproductive Health, Medical Siences Division, Oxford University, Oxford, UK.

Abstract

High-grade poorly differentiated sarcomas of unknown primary origin constitute a rare entity and are characterised by wide histopathological diversity and atypical presentations. We present such an unusual case attending with severe procidentia in a 68-year-old postmenopausal female. On review of the literature, there are no similar cases reported. Herein, we present this case as in view of its rare clinical appearance combined with the advanced and histologically uncertain nature of the tumour, which raised significant challenges regarding diagnosis and surgical management in considerations of oncological hygiene and risk of tumour spillage. This was further potentiated by delay in diagnosis and treatment due to the COVID-19 pandemic.

Keywords: COVID-19; cancer - see oncology; pathology; surgical oncology.

Publication types

Case Reports

MeSH terms

Aged
COVID-19*
Female
Humans
Pandemics
SARS-CoV-2
Sarcoma* / diagnosis